Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
boston blog main
boulder/denver blog main
boulder/denver top stories
deals
9
×
detroit blog main
detroit top stories
fda
9
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
9
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
9
×
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer
cancer immunotherapy
investing
clinical trials
pfizer
takeda pharmaceutical
amag pharmaceuticals
astrazeneca
duchenne muscular dystrophy
eli lilly
What
roundup
bio
cancer
develop
drugs
ahead
amid
asco
bombast
cash
caught
coronavirus
days
debate
discussion
drug
efforts
fda
growing
meso’s
miss
pandemic
pfizer’s
pharmaceutical
presidential
promise
response
tuesday’s
vaccine
viewers
acquisitions
alliance
ambien
american
announced
annual
appetite
approved
attendees
attention
Language
unset
Current search:
fda
×
deals
×
" seattle top stories "
×
" new york top stories "
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More